Phantom limb pain (PLP) is a complex condition that affects many individuals who have undergone limb amputation. Traditional pharmacological treatments often provide limited relief and can lead to undesirable side effects. Recent research has explored alternative therapies, particularly virtual reality (VR) therapy, which has shown promise in alleviating PLP.
The objective of this controlled trial is to compare the efficacy of virtual reality therapy against traditional pharmacological treatments in reducing phantom limb pain, while also measuring quality of life indicators.
Primary outcomes will include:
Based on previous studies, it is anticipated that the VR therapy group will demonstrate a statistically significant reduction in pain levels compared to the pharmacological group. For instance, a study indicated a 47% reduction in weighted pain distribution and a 51% reduction in pain rating index after VR therapy .
This trial aims to provide robust evidence on the efficacy of VR therapy as a non-invasive treatment for PLP. By comparing it to traditional pharmacological treatments, the study seeks to highlight the potential of innovative therapies in improving patient outcomes and quality of life.
The integration of virtual reality therapy into pain management strategies for phantom limb pain could represent a significant advancement in treatment options, potentially reducing reliance on medications and enhancing overall patient well-being.